middle.news
Rua’s UK deal tests whether revenue momentum can outrun its funding needs
1:44pm on Tuesday 22nd of September, 2026 AEST
•
Healthcare
Read Story
Rua’s UK deal tests whether revenue momentum can outrun its funding needs
1:44pm on Tuesday 22nd of September, 2026 AEST
Key Points
Customer revenue up 71% to NZ$2.58 million
PwC disclaims opinion over going-concern uncertainty
NZ$2.83 million one-for-three rights offer launched
UK agreement expected to generate NZ$10 million over two years
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
RUA Bioscience (NZX:RUA)
OPEN ARTICLE